Faced with allegations that they inundated the country with addictive painkillers by deceiving doctors and the public about their safety, a group of drug companies went on the attack against their accusers. This week, plaintiffs lawyers at Cohen, Milstein, Sellers & Toll took a step toward putting the drugmakers back on the defensive.
U.S. District Judge Elaine Bucklo in Chicago refused Monday to disqualify Cohen Milstein and partner Linda Singer from representing the city of Chicago, which sued a half-dozen drug companies in June over their “highly deceptive” marketing of opioid painkillers. OxyContin maker Purdue Pharma Inc. had taken aim at Singer over her past role as attorney general for Washington, D.C, which previously reached a settlement with Purdue over its blockbuster painkiller.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
